- Home
- KRKR vs QNTM Comparison
KRKR vs QNTM Comparison
Compare KRKR & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- QNTM
- Stock Information
- Founded
- KRKR 2010
- QNTM 1998
- Country
- KRKR China
- QNTM Canada
- Employees
- KRKR N/A
- QNTM N/A
- Industry
- KRKR Business Services
- QNTM
- Sector
- KRKR Consumer Discretionary
- QNTM
- Exchange
- KRKR Nasdaq
- QNTM NYSE
- Market Cap
- KRKR 9.1M
- QNTM 8.7M
- IPO Year
- KRKR 2019
- QNTM N/A
- Fundamental
- Price
- KRKR $4.02
- QNTM $7.95
- Analyst Decision
- KRKR
- QNTM
- Analyst Count
- KRKR 0
- QNTM 0
- Target Price
- KRKR N/A
- QNTM N/A
- AVG Volume (30 Days)
- KRKR 19.8K
- QNTM 1.5M
- Earning Date
- KRKR 03-11-2025
- QNTM 05-13-2025
- Dividend Yield
- KRKR N/A
- QNTM N/A
- EPS Growth
- KRKR N/A
- QNTM N/A
- EPS
- KRKR N/A
- QNTM N/A
- Revenue
- KRKR $31,657,328.00
- QNTM N/A
- Revenue This Year
- KRKR $182.55
- QNTM N/A
- Revenue Next Year
- KRKR N/A
- QNTM N/A
- P/E Ratio
- KRKR N/A
- QNTM N/A
- Revenue Growth
- KRKR N/A
- QNTM N/A
- 52 Week Low
- KRKR $2.76
- QNTM $2.70
- 52 Week High
- KRKR $12.99
- QNTM $44.72
- Technical
- Relative Strength Index (RSI)
- KRKR 48.56
- QNTM 58.15
- Support Level
- KRKR $3.93
- QNTM $6.45
- Resistance Level
- KRKR $4.26
- QNTM $12.45
- Average True Range (ATR)
- KRKR 0.21
- QNTM 1.65
- MACD
- KRKR 0.03
- QNTM 0.23
- Stochastic Oscillator
- KRKR 40.35
- QNTM 35.06
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.